I think if you put the imu chart next to the ptx chart, then we...

I think if you put the imu chart next to the ptx chart, then we see a similar mountain.

Imu became worth 3 billion, but ptx had omni-car, the next generation CAR-T and something extra special.

It seemed ptx was undervalued, having a mkt cap of 10% that of imu.

But a big difference is imu is a doer. If they had omni-car then the three clinical trials ptx talk about would have been started long ago (probably).

It takes cash to realise the dream, and imu have raised many times.

But the imu way is certainly the way to go. The next months could be massive over there, as the cf33 doses get higher and higher.

Cheers

Ps. We could start to see some Cell Pryme deals and then we will be writing how great ptx is, doing all this without dilution!